Literature DB >> 9385101

Statistical methods for dependent competing risks.

M L Moeschberger1, J P Klein.   

Abstract

Many biological and medical studies have as a response of interest the time to occurrence of some event, X, such as the occurrence of cessation of smoking, conception, a particular symptom or disease, remission, relapse, death due to some specific disease, or simply death. Often it is impossible to measure X due to the occurrence of some other competing event, usually termed a competing risk. This competing event may be the withdrawal of the subject from the study (for whatever reason), death from some cause other than the one of interest, or any eventuality that precludes the main event of interest from occurring. Usually the assumption is made that all such censoring times and lifetimes are independent. In this case one uses either the Kaplan-Meier estimator or the Nelson-Aalen estimator to estimate the survival function. However, if the competing risk or censoring times are not independent of X, then there is no generally acceptable way to estimate the survival function. There has been considerable work devoted to this problem of dependent competing risks scattered throughout the statistical literature in the past several years and this paper presents a survey of such work.

Entities:  

Mesh:

Year:  1995        PMID: 9385101     DOI: 10.1007/bf00985770

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  13 in total

1.  A review and critique of some models used in competing risk analysis.

Authors:  M Gail
Journal:  Biometrics       Date:  1975-03       Impact factor: 2.571

2.  Estimates of absolute cause-specific risk in cohort studies.

Authors:  J Benichou; M H Gail
Journal:  Biometrics       Date:  1990-09       Impact factor: 2.571

3.  Applications of crude incidence curves.

Authors:  E L Korn; F J Dorey
Journal:  Stat Med       Date:  1992-04       Impact factor: 2.373

4.  Bounds for a joint distribution function with fixed sub-distribution functions: Application to competing risks.

Authors:  A V Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

5.  Methods for bounding the marginal survival distribution.

Authors:  J J Dignam; L A Weissfeld; S J Anderson
Journal:  Stat Med       Date:  1995-09-30       Impact factor: 2.373

6.  How dependent causes of death can make risk factors appear protective.

Authors:  E Slud; D Byar
Journal:  Biometrics       Date:  1988-03       Impact factor: 2.571

7.  The analysis of failure times in the presence of competing risks.

Authors:  R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal:  Biometrics       Date:  1978-12       Impact factor: 2.571

8.  Bounds on net survival probabilities for dependent competing risks.

Authors:  J P Klein; M L Moeschberger
Journal:  Biometrics       Date:  1988-06       Impact factor: 2.571

9.  Dependent competing risks and the latent-failure model.

Authors:  E V Slud; D P Byar; A Schatzkin
Journal:  Biometrics       Date:  1988-12       Impact factor: 2.571

10.  A concordance test for independence in the presence of censoring.

Authors:  D Oakes
Journal:  Biometrics       Date:  1982-06       Impact factor: 2.571

View more
  7 in total

Review 1.  Logistic or Cox model to identify risk factors of nosocomial infection: still a controversial issue.

Authors:  S Chevret
Journal:  Intensive Care Med       Date:  2001-10       Impact factor: 17.440

2.  Competing risks analysis of correlated failure time data.

Authors:  Bingshu E Chen; Joan L Kramer; Mark H Greene; Philip S Rosenberg
Journal:  Biometrics       Date:  2007-08-03       Impact factor: 2.571

3.  Mode of death in heart failure: findings from the ATLAS trial.

Authors:  P A Poole-Wilson; B F Uretsky; K Thygesen; J G F Cleland; B M Massie; L Rydén
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 4.  Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.

Authors:  Kelly M Haston; Steven Finkbeiner
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-28       Impact factor: 13.820

5.  Nodal microinvolvement in patients with carcinoma of the papilla of vater receiving no adjuvant chemotherapy.

Authors:  Dean Bogoevski; Hassan Chayeb; Guell Cataldegirmen; Paulus G Schurr; Jussuf T Kaifi; Oliver Mann; Emre F Yekebas; Jakob R Izbicki
Journal:  J Gastrointest Surg       Date:  2008-09-13       Impact factor: 3.452

6.  A comparison of epinephrine and norepinephrine in critically ill patients.

Authors:  John A Myburgh; Alisa Higgins; Alina Jovanovska; Jeffrey Lipman; Naresh Ramakrishnan; John Santamaria
Journal:  Intensive Care Med       Date:  2008-07-25       Impact factor: 17.440

7.  Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients.

Authors:  K Ranh Voong; Jon Davison; Timothy M Pawlik; Manuel O Uy; Charles C Hsu; Jordan Winter; Ralph H Hruban; Daniel Laheru; Sonali Rudra; Michael J Swartz; Hari Nathan; Barish H Edil; Richard Schulick; John L Cameron; Christopher L Wolfgang; Joseph M Herman
Journal:  Hum Pathol       Date:  2009-10-03       Impact factor: 3.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.